Advertisement

Design, Synthesis, Antioxidant and Antibacterial Activities of Novel 2-((1-Benzyl-1H-1,2,3-Triazol-4-yl)methyl)-5-(2HChromen- 3-yl)-2H-Tetrazoles

  • 78 Accesses

  • 3 Citations

Abstract

1,4-Disubstituted 1,2,3-triazole derivatives of 2H-chromene-3-tetrazoles synthesized regioselectively by copper(I)-catalyzed alkyne–azide cycloaddition (CuAAC) click reaction were characterized by 1HNMR, 13C NMR, IR, and mass spectral data. These derivatives were screened for in vitro antioxidant activity using DPPH radical, H2O2 scavenging, and iron chelating activity methods and also evaluated for in vitro antibacterial activities against E. coli and S. aureus bacterial strains. The MIC and IC50 values for all these compounds were found to match the docking scores and relevant binding energies with the receptor active sites. These results allows one to consider the compounds as leads for a new generation of antioxidant and antibacterial agents.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

References

  1. 1.

    Ren, Q., Siau, W.-Y., Du, Z., Zhang, K., and Wang, J., Chem. Eur. J., 2011, vol. 17, pp. 7781–7785.

  2. 2.

    Laskar, S. and Brahmachari, G., Signpost Open Access J. Org. Biomol. Chem., 2014, vol. 2, pp. 1–50.

  3. 3.

    Lauria, A., Delisi, R., Mingoia, F., Terenzi, A., Martorana, A., Barone, G., and Almerico, A.M., Eur. J. Org. Chem., 2014, pp. 3289–3306.

  4. 4.

    Rong, L.Y., Yuan, C.P., Yeu, C.L., Fang, L.Y. Tsai, I.L., Chi, W.E., Tetrahedron Lett., 2009, vol. 20, p. 2121.

  5. 5.

    Khafagy, M.M., El-Wahas, A.H.F.A., Eid, F.A., and El-Agrody, A.M., Farmaco, 2002, vol. 57, pp. 715–722.

  6. 6.

    Smith, P.W., Sollis, S.L., Howes, P.D., Cherry, P.C., Starkey, I.D., Cobley, K.N., Weston, H., Scicinski, J., Merritt, A., Whittington, A., Wyatt, P., Taylor, N., Green, D., Bethell, R., Madar, S., Fenton, R.J., Morley, P. J., Pateman, T., and Beresford, A., J. Med. Chem., 1998, vol. 41, pp. 787–797.

  7. 7.

    Martinez, A.G. and Marck, L., J. Bioorg. Med. Chem. Lett., 1997, vol. 7, pp. 3165–3170.

  8. 8.

    Moon, D.O., Choi, Y.H., Kim, N.D., Park, Y.M., and Kim, G.Y., Int. Immunopharmacol., 2007, vol. 7, pp. 506–514.

  9. 9.

    De Andrade-Neto, V.F., Goulart, M.O.F., Da Silva Filho, J.F., Da Silva, M.J., Pinto, M.D.C.F.R., Pinto, A.V., Zalis, M.G., Carvalho, L.H., and Krettli, A.U., Bioorg. Med. Chem. Lett., 2004, vol. 14, pp. 1145–1149.

  10. 10.

    Elisa, P.S, Ana, E.B, Ravelo, A.G., Yapu, D.J., and Turba, A.G., Chem. Biodivers., 2005, vol. 2, pp. 264–274.

  11. 11.

    Mohr, S.J., Chirigios, M.A., Fuhrman, F.S., and Pryor, J.W., Cancer Res., 1975, vol. 35, pp. 3750–3754.

  12. 12.

    Bianchi, G. and Tava, A., Agric. Biol. Chem., 1987, vol. 51, pp. 2001–2002.

  13. 13.

    Anderson, D.R., Hegde, S., Reinhard, E., Gomez, L., Vernier, W.F., Lee, L., Liu, S., Sambanda, A., Sinder, P.A., and Masih, L., Bioorg. Med. Chem. Lett., 2005, vol. 15, pp. 1587–1590.

  14. 14.

    Ough, M., Lewis, A., Bey, E.A., Gao, J., Ritchie, J.M., Bornmann, W., Boothman, D.A., Oberley, L.W., and Cullen, J.J., Cancer Biol. Ther., 2005, vol. 4, pp. 95–102.

  15. 15.

    Li, C.J. and Li, Y.L., 2005, US Patent Appl. Publ. U.S.2, 005, 222, 246 Al 20, 051, 006.

  16. 16.

    Ellis, G.P., in Weissberger, A. and Taylor, E.C., Eds., New York: John Wiley, 1977, ch. II, pp. 11–139.

  17. 17.

    Abdel Galil, F.M, Riad, B.Y, Sherif, S.M, and Elnagdi, M.H., Chem. Lett., 1982, pp. 1123–1126.

  18. 18.

    Sofan, M.A., El-Taweel, F.M.A., and Elnagdi, M.H., Liebigs. Ann. Chem. 1989, vol. 27, pp. 935–938.

  19. 19.

    Ostroviskii, V.A., Koldoboskii, G.I., and Trifonov, R.E., Comp. Heterocycl. Chem. III, 2008, vol. 6, p. 257.

  20. 20.

    Tremblay, L.W., Xu, H., and Blanchard, J.S., Biochemistry, 2010, vol. 49, p. 9685.

  21. 21.

    Vilain, S., Cosette, P., Junter, G.A., and Jouenne, T., J. Antimicrob. Chemother., 2002, vol. 49, p. 315.

  22. 22.

    Yang, Y., Rasmussen, B.A., and Shlaes, D.M., Pharmacol. Ther., 1999, vol. 83, pp. 141–151.

  23. 23.

    Sheng, C. and Zhang, W., Curr. Med. Chem., 2011, vol. 18, pp. 733–766.

  24. 24.

    Weinstein, A.J., Drugs, 1980, vol. 20, pp. 137–154.

  25. 25.

    Soltis, M., Yeh, H., Cole, K., Whittaker, N., Wersto, R., and Kohn, E., Drug Metab. Dispos., 1996, vol. 24, pp. 799–806.

  26. 26.

    Perucca, E., Cloyd, J., Critchley, D., and Fuseau, E., Epilepsia, 2008, vol. 49, pp. 1123–1141.

  27. 27.

    Prasad, D.J., Ashok, M., Karegoudar, P., Poojary, B., Holla, B.S., and Kumari, N.S., Eur. J. Med. Chem., 2009, vol. 44, pp. 551–557.

  28. 28.

    Walczak, K., Gondela, A., and Suwinski, J., Eur. J. Med. Chem., 2004, vol. 39, pp. 849–853.

  29. 29.

    Holla, B.S., Poojary, K.N., Rao, B.S., and Shivananda, M.K., Eur. J. Med. Chem., 2002, vol. 37, pp. 511–517.

  30. 30.

    Amir, M. and Shikha, K., Eur. J. Med. Chem., 2004, vol. 39, pp. 535–545.

  31. 31.

    Almasirad, A., Tabatabai, S.A., Faizi, M., Kebriaeezadeh, A., Mehrabi, N., Dalvandi, A., and Shafiee, A., Bioorg. Med. Chem. Lett., 2004, vol. 14, pp. 6057–6059.

  32. 32.

    Masuda, K, Toga, T., and Hayashi, N., J. Label. Compd. Radiopharm, 1975, vol. 11, pp. 301–304.

  33. 33.

    S. Satyanarayana Reddy and G. L. David Krupadanam, Synth. Commun., 2010, vol. 40, no. 9, pp. 1292–1304.

  34. 34.

    Baylis, A.B. and Hillman, M.E.D., German Patent no. 2155113, 1972.

  35. 35.

    Pressnitz, D., Fuchs, C.S., Sattler, J.H., Knaus, T., Macheroux, P., Mutti, F.G., and Kroutil, W., Acs. Catalysis, 2013, vol. 3, no. 4, pp. 555–559.

  36. 36.

    Atoni, P.H., Yvonne, N.X., Nystrom, D.H.H., Hult, A., and Malkoch, M., Angew. Chem., Int. Ed., 2009, vol. 48, p. 2126.

  37. 37.

    Rostovtsev, V.V., Green, L.G., Fokin, V.V., and Sharpless, K.B., Angew. Chem., Int. Ed., 2002, vol. 41, pp. 2596–2599.

  38. 38.

    Koteswara Reddy, M., Santosh Kumar, K., Sreenivas, P., David Krupadanam, G.L., and Janardhan Reddy, K., Tetrahedron Lett., 2011, vol. 52, pp. 6537–6540.

  39. 39.

    Chenot, E.-D., Rodriguez Dominguez, J.C., Hannewald, P., Comel, A., and Kirsch, G., J. Heterocyclic Chem., 2008, vol. 45, p. 1429.

  40. 40.

    Shisode, K.S. and Kareppa, B.M., IJPSR, 2011, vol. 2, no. 12, pp. 3171–3176.

  41. 41.

    Nilesh, J., Patel, N., and Patel, J., Pharmacology online, 2010, vol. 2, pp. 681–688.

  42. 42.

    Benzie, I.F. and Strain, J.J., Anal. Biochem., 1996, vol. 239, no. 1, pp.70–76.

  43. 43.

    Saini, R.K, Choudhary, A.S, Joshi, Y.C., and Joshi, P., E-J. Chem., 2005, vol. 2, no. 4, pp. 224–227.

  44. 44.

    Bhuiyan, M.M.H., Hossain, M.I., and Al-Amin, M.M., Chem. J., 2011, vol. 1, no. 1, pp. 21–28.

  45. 45.

    Shah Shailesh, H. and Patel Pankaj, S., Res. J. Chem. Sci., 2012. vol. 2, no. 7, pp. 62–68.

  46. 46.

    Lafitte, D., Lamour, V., Tsvetkov, P.O., Makarov, A.A., Klich, M., Deprez, P., Moras, D., Briand, C., and Gilli, R., Biochemistry, 2002, vol. 41, no. 23, pp. 7217–7223. PubMed PMID: 12044152

  47. 47.

    Shyam Perugu, Harika Jalli, and Manjula Bhanoori, Int. J. Innovat. Technol. Explor. Eng., 2013, vol. 3, no. 4, pp. 2278–3075.

Download references

Author information

Correspondence to G. L. David Krupadanam.

Additional information

The article is published in the original.

Supplementary materials are available for this article at 10.1134/S1068162018020097 and are accessible for authorized users.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Srinivas, B., Kumar, P.V., Nagendra Reddy, P. et al. Design, Synthesis, Antioxidant and Antibacterial Activities of Novel 2-((1-Benzyl-1H-1,2,3-Triazol-4-yl)methyl)-5-(2HChromen- 3-yl)-2H-Tetrazoles. Russ J Bioorg Chem 44, 244–251 (2018). https://doi.org/10.1134/S1068162018020097

Download citation

Keywords

  • 2H-chromene
  • 1,2,3,4-tetrazoles
  • 1,2,3-triazoles
  • antioxidant activity
  • antibacterial activity
  • molecular docking studies